A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics
Citations Over TimeTop 10% of 2016 papers
Abstract
Three-dimensional (3D) culture, which can simulate in vivo microenvironments, has been increasingly used to study tumor cell biology. Since most preclinical anti-glioma drug tests still rely on conventional 2D cell culture, we established a collagen scaffold for 3D glioma cell culture. Glioma cells cultured on these 3D scaffolds showed greater degree of dedifferentiation and quiescence than cells in 2D culture. 3D-cultured cells also exhibited enhanced resistance to chemotherapeutic alkylating agents, with a much higher proportion of glioma stem cells and upregulation of O6-methylguanine DNA methyltransferase (MGMT). Importantly, tumor cells in 3D culture showed chemotherapy resistance patterns similar to those observed in glioma patients. Our results suggest that 3D collagen scaffolds are promising in vitro research platforms for screening new anti-glioma therapeutics.
Related Papers
- → Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines(2009)91 cited
- → From 2D to 3D: The morphology, proliferation and differentiation of MC3T3-E1 on silk fibroin/chitosan matrices(2017)36 cited
- → miR-720 is a key regulator of glioma migration and invasion by controlling TARSL2 expression(2021)9 cited
- → Glioblastoma: Temozolomide-Based Chemotherapy(2010)1 cited
- → Rechallenge of malignant gliomas with Temozolomide – can it be effective?(2007)1 cited